razoxane has been researched along with Kaposi Sarcoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olweny, CL | 1 |
Vogel, CL | 1 |
Bayley, AC | 1 |
Olweny, CL; Otim, D; Sikyewunda, W | 1 |
Masaba, JP; Olweny, CL; Sikyewunda, W; Toya, T | 1 |
Chachoua, A; Green, M; Muggia, F; Wernz, J | 1 |
1 review(s) available for razoxane and Kaposi Sarcoma
Article | Year |
---|---|
Management of Kaposi's sarcoma. Chemotherapy I.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Carmustine; Dactinomycin; Humans; Immunosuppressive Agents; Prednisone; Razoxane; Sarcoma, Kaposi; Vinca Alkaloids | 1981 |
1 trial(s) available for razoxane and Kaposi Sarcoma
Article | Year |
---|---|
Management of Kaposi's sarcoma. Chemotherapy II.
Topics: Bleomycin; Carmustine; Clinical Trials as Topic; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Humans; Razoxane; Sarcoma, Kaposi; Uganda; Vincristine | 1981 |
4 other study(ies) available for razoxane and Kaposi Sarcoma
Article | Year |
---|---|
Role of surgery in the management of Kaposi's sarcoma in Lusaka Zambia.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Arm; Arthrodesis; Dactinomycin; Electrocoagulation; Humans; Leg; Male; Middle Aged; Razoxane; Sarcoma, Kaposi; Vincristine; Zambia | 1981 |
Further experience with rezoxane (ICRF 159; -- NSC --129943) in treating Kaposi's sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Humans; Leukopenia; Male; Middle Aged; Piperazines; Razoxane; Remission, Spontaneous; Sarcoma, Kaposi; Time Factors | 1980 |
Treatment of Kaposi's sarcoma with ICRF-159 (NSC-129943).
Topics: Adolescent; Adult; Aged; Child; Humans; Middle Aged; Piperazines; Razoxane; Sarcoma, Kaposi | 1976 |
Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).
Topics: Acquired Immunodeficiency Syndrome; Drug Evaluation; Drugs, Investigational; Hematologic Diseases; Humans; Male; Middle Aged; Piperazines; Razoxane; Sarcoma, Kaposi; Stereoisomerism | 1989 |